Congresswoman Dingell Honored as Innovator in Biotechnology

WASHINGTON–(BUSINESS WIRE)–Congresswoman Debbie Dingell was recognized today by the Biotechnology
Innovation Organization (BIO) for her leadership as an Innovator in
Biotechnology. Congresswoman Dingell received the award in conjunction
with today’s BIO Legislative Day Fly-In.

BIO’s Innovator in Biotechnology award recognizes Members of Congress
who have been collaborative partners, advocates, and champions of the
biotechnology and life sciences industries.

“The life sciences industry in Michigan provides jobs for over 40,000
people. Congresswoman Dingell has been an invaluable advocate for the
biotechnology community – both in Michigan’s 12th District and the
nation at large,” said Stephen Rapundalo, PhD and President & CEO of the
Michigan Bioscience Industry Association – MichBio. “On behalf of the
Michigan life science industry, we thank her for outstanding leadership
and dedication to supporting the innovative capacity and job-creating
potential of American life science companies.”

“Congresswoman Dingell has been a stalwart advocate for sound public
policies that advance the jobs creating potential of America’s
biotechnology industry as we address the most pressing medical,
agricultural, industrial and environmental challenges facing our nation
and the world,” said BIO President and CEO Jim Greenwood. “Her
commitment to support the needs of America’s innovative life science
companies allows them to focus on what matters – delivering life-saving
and life-enhancing products.”

More than 200 biotechnology industry representatives from over 40
states, representing hundreds of thousands of American workers, will
participate in hundreds of meetings with Members of the House and Senate
during the BIO Legislative Day Fly-In. Participants will discuss issues
critical to the biotechnology industry, including drug development,
discovery and delivery reforms, targeting abuses of the U.S. patent
system while protecting innovation, providing adequate reimbursement for
vital therapies under Medicare, FDA funding, trade, tax policy, Farm
Bill Implementation, protecting the Renewable Fuel Standard and capital
formation issues relevant to biotechnology companies.

For more information on MichBio visit www.michbio.org.

For more information on BIO visit www.bio.org.

Michigan Biosciences Industry Association (MichBio) is the recognized
voice as well as the foremost source of information, advocacy and
resources in Michigan for the biosciences industry.

Photos of the award presentation are available upon request.

Contacts

Alisha Brown
Director of Marketing and Communications, MichBio
[email protected]
| 734-527-9147